Viral infectious disease IVDs
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
06-11-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Abbott Australasia Pty Ltd Molecular Division
Class:
Class 2
Manufactured by:
Abbott Molecular Inc 1300 East Touhy Avenue, Des Plaines, Illinois, 60018 United States Of America
Therapeutic area:
CT355 - Viral infectious disease IVDs
Therapeutic indications:
For the determination of virus markers in human clinical specimens.
Authorization status:
A
Authorization date:
2015-11-25
